Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Veracyte Inc
(NQ:
VCYT
)
31.63
-0.06 (-0.19%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Veracyte Inc
< Previous
1
2
3
4
Next >
Thermo Fisher Scientific Stock Sees RS Rating Jump To 81
August 13, 2024
Thermo Fisher Scientific stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 77 to 81.
Via
Investor's Business Daily
Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
August 11, 2024
Lumen, Upstart, ADMA, Sweetgreen, Veracyte, Clear Secure, and Core Scientific were best performers last week. Did you invest in them?
Via
Benzinga
Diagnostic Tests Maker Veracyte's Q2 Is 'All-Around Very Good Quarter': Analysts Maintain Bullish View
August 07, 2024
Veracyte reports Q2 sales of $114.43M, a 27% increase year over year, surpassing the $100.3 million consensus. Testing revenue rose 31% to $107 million, driven by strong performance of Decipher...
Via
Benzinga
Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday
August 07, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Veracyte Through 4 Analysts
May 08, 2024
Via
Benzinga
Recap: Veracyte Q4 Earnings
February 22, 2024
Via
Benzinga
Earnings Outlook For Veracyte
February 21, 2024
Via
Benzinga
Veracyte: Q3 Earnings Insights
November 07, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
August 07, 2024
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!
Via
InvestorPlace
VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
VCYT stock results show that Veracyte beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
The 3 Best Personalized Nutrition Stocks to Buy Now
July 24, 2024
Explore personalized nutrition stocks capitalizing on AI, machine learning and genetic profiling to provide targeted dietary solutions.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...
Via
Talk Markets
The Latest Analyst Ratings for Veracyte
October 20, 2023
Via
Benzinga
Here's Why This Little-Known Growth Stock Is a Buy
May 22, 2023
Analysts think this genomic test maker could have major upside in the next year.
Via
The Motley Fool
Looking Into Veracyte's Return On Capital Employed
May 17, 2023
Via
Benzinga
Cathie Wood-Lead Ark Invest Dumps $7.6M Worth Of Robinhood Shares Amid GameStop Buzz, Bitcoin Choppiness
June 10, 2024
On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). This decision came amidst a period of market fluctuations and followed a...
Via
Benzinga
VCYT Stock Earnings: Veracyte Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
VCYT stock results show that Veracyte beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Cathie Wood's Ark Invest Dumps $17M In Coinbase Shares As The Exchange Grappled With Disruption Amid Bitcoin Rally
February 28, 2024
On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASDAQ:COIN) shares.
Via
Benzinga
Cathie Wood's Ark Invest Sheds $9.3M Worth Of Coinbase Shares Amid Bitcoin Rally — Robinhood Stock Also Sold
February 27, 2024
On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades.
Via
Benzinga
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
February 26, 2024
On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ:
Via
Benzinga
7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff
February 26, 2024
Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.
Via
InvestorPlace
Cathie Wood's Ark Invest Buys Over $92M Worth Of ProShares Bitcoin ETF, Sells Coinbase, Block And Palantir Shares
December 27, 2023
On Wednesday, Cathie Wood-led Ark Invest made a significant move in the cryptocurrency space, purchasing over $92 million worth of ProShares Bitcoin Strategy ETF (NYSE:BITO).
Via
Benzinga
Topics
ETFs
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
November 20, 2023
ETFs have not helped as portfolio fillers but they can identify trends. We should play this rally out of a biotech bear market.
Via
Talk Markets
Topics
ETFs
Earnings Scheduled For February 22, 2024
February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
Via
Benzinga
Earnings Scheduled For November 7, 2023
November 07, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
Via
Benzinga
7 Undervalued Stocks That Analysts Love Right Now
October 26, 2023
With many investors concerned about what may lie ahead in the market, these potentially de-risked undervalued stocks may be ideal.
Via
InvestorPlace
Veracyte Stock Is Volatile After-Hours - Here's Why
October 04, 2023
Veracyte, Inc. (NASDAQ: VCYT) shares are volatile after-hours on Wednesday after the company announced that new data from a phase 3 trial validates the value of the Decipher Prostate Genomic Classifier...
Via
Benzinga
Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors?
September 02, 2023
The genetic test maker is rapidly increasing test volumes.
Via
The Motley Fool
Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom
July 08, 2023
AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider.
Via
InvestorPlace
Market Mixes It Up With A Broad Rally
June 05, 2023
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.
Via
Talk Markets
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.